Author:
Willis English D.,Woodward Meredith,Brown Elizabeth,Popmihajlov Zoran,Saddier Patricia,Annunziato Paula W.,Halsey Neal A.,Gershon Anne A.
Funder
Merck & Co., Inc., Kenilworth, NJ, USA
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine
Reference46 articles.
1. U.S. Food and Drug Administration. Approved Products: Zostavax. 2016. [Accessed 23 March 2017].
2. European Medicines Agency. Summary of Product Characterstics: Zostavax. 2016. [Accessed 23 March 2017].
3. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults;Oxman;N Engl J Med,2005
4. Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50–59 years;Schmader;Clin Infect Dis,2012
5. Persistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudy;Schmader;Clin Infect Dis,2012
Cited by
79 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献